Strikingly, pre-treatment of both cell types with catalase abrogated cell death induction in GSH + PEF combined treatments to baseline levels, ultimately leading to a significantly reduced cytotoxicity in A375 (Figure 4F) and A431 (Figure 4H) skin cancer cells. This evidence concerns the gene CAT and skin cancer.